Correction to: Cell Death & Differentiation
https://doi.org/10.1038/s41418-020-00717-4 Published: 19 January 2021
The original version of this article unfortunately contained a mistake. It should have included a reference to another article in Cell Death & Disease. The author has asked to add the reference to the start of paragraph 3, first sentence: In this issue of Cell Death and Disease, Vervloessem et al. [8] have convincingly challenged the original hypothesis that BDA-366 targets BCL2. This also results in the renumbering of references 8-14. The added reference is: Vervloessem T, Sasi B.K., Xerxa E, Karamanou S, Kale J, La Rovere R.M. et al. BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models. Cell Death Dis. 2020;11:769. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Birkinshaw, R.W. Correction to: Challenges in small-molecule target identification: a commentary on “BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models”. Cell Death Differ 28, 2553 (2021). https://doi.org/10.1038/s41418-021-00758-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41418-021-00758-3